PharmAust |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 7:29am | ||||
|
Market Cap (13-Nov) $111,926,056 (1,449th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 0 |
Shortsold (11-Oct) 108,089 (0.02%) (492nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
PharmAust receives $210k prepayment of forecast R&D rebate
PAA released this announcement to the ASX on 17 May 2022, 11:11. The announcement is marked as price sensitive, and is 1 page(s) in length and 188.38kb in size.
You can view all announcements from PAA and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAA was 0.072% short sold according to ASIC data. It was ranked the 487th most shorted stock on the ASX. It remains ranked 492nd as of the latest reported data (11 October 2024).
| Other Recent Announcements from PAA | |
|---|---|
| Results of General Meeting | 30 June 2023, 12:38 |
| Trading Halt | 30 June 2023, 9:48 |
| General Meeting - Chairman Script | 30 June 2023, 9:42 |
| PharmAust receives $210k prepayment of forecast R&D rebate | 17 May 2022, 11:11 |
| MPL tablets arrive in Melbourne for MND Clinical Trial | 16 May 2022, 8:28 |
| PharmAust Expands Lymphoma Canine Trial to the USA | 11 May 2022, 8:25 |
| Notification of cessation of securities - PAA | 29 April 2022, 16:48 |
If you were already registered, log in here.